← Back to Clinical Trials
Recruiting NCT06443281

Pain Phenotyping in Patients With Neuropathic Pain After Spinal Cord Injury

Trial Parameters

Condition Spinal Cord Injuries
Sponsor University of Zurich
Study Type OBSERVATIONAL
Phase N/A
Enrollment 300
Sex ALL
Min Age 18 Years
Max Age 80 Years
Start Date 2024-04-17
Completion 2030-04-30
Interventions
NeurophysiologyCardiovascular testExperimental pain paradigms

Brief Summary

The development of neuropathic pain is one of the most debilitating sequels after a spinal cord injury (SCI). The overall aim of this study is to investigate potential underlying pathophysiological mechanisms of neuropathic pain after SCI. The functionality of the nociceptive pathway in humans as well as its plastic changes following SCI will be inferred with sophisticated sensory and pain phenotyping using quantitative sensory testing (i.e., psychophysical measures), objective neurophysiological measures of pain processing and the recording of pain-related autonomic responses (i.e., galvanic skin response, cardiovascular measures and pupil dilation). In addition, the interplay between the somatosensory and autonomic nervous system and its association with the development and maintenance of neuropathic pain after SCI will be investigated.

Eligibility Criteria

Inclusion Criteria: * Spinal injury cohort - general inclusion criteria: * Aged between 18-80 years * Traumatic and non-traumatic etiology * Para- and tetraplegic SCI * Complete and incomplete SCI * SCI with and without neuropathic pain * Additional inclusion criteria for longitudinal study: * SCI since less than one month * Additional inclusion criteria for cross-sectional study: * SCI since more than one year * Control cohorts with peripheral neuropathy: * General inclusion criteria: * Aged between 18-80 years * Neurological disorder affecting the peripheral nervous system (i.e., peripheral neuropathy) * Peripheral neuropathy with or without neuropathic pain * Additional inclusion criteria for longitudinal study: * Peripheral neuropathy since less than one month * Additional inclusion criteria for cross-sectional study: * Peripheral neuropathy since more than one year * Control cohorts without neuropathy / healthy volunteers * General inclusion criteria: * Aged between 18-80 years *

Related Trials